Advertisement

Differential diagnosis of early Alzheimer’s disease

  • C. G. Gottfries
Part of the New Vistas in Drug Research book series (DRUG RESEARCH, volume 1)

Summary

The concept of Alzheimer type dementia, as used today, does not imply a homogeneous group of dementias. There is no scientific basis for sampling the presenile form, Alzheimer’s disease (AD), with the senile dementia of the Alzheimer type (SDAT). The rare form of AD seems to be fairly homogeneous. SDAT is much more common than AD and is, evidently, a heterogeneous group. The differentiation of the subgroups is made by thorough clinical investigation, brain imaging techniques and analysis of cerebrospinal fluid and blood. Data indicate that AD is a cortical disorder, while SDAT also involves subcortical areas. The differentiation between SDAT and secondary dementias, such as vitamin B 12 deficiency and leukoaraiosis, is difficult. The SDAT group is assumed to include also forms of normal aging with cognitive impairment.

Keywords

Vascular Dementia Monoamine Metabolite Alzheimer Type Dementia Dementia Disorder Subcortical Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adolfsson R, Gottfries CG, Nyström L, Winblad B (1981) Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 63: 245–252CrossRefGoogle Scholar
  2. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral matter of elderly subjects. Br J Psychiatry 114: 797–811PubMedCrossRefGoogle Scholar
  3. Bråne (1989) The GBS scale — a geriatric rating scale — and its clinical application. Dissertation, Gothenburg University, SwedenGoogle Scholar
  4. Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A (1989) Monoamine metabolites in cerebrospinal fluid and behavioural ratings in patients with early and late onset of Alzheimer’s dementia. Alz Dis Assoc Disord 3: 148–156CrossRefGoogle Scholar
  5. Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer’s disease. A clinicopathological study. Arch Psychiatr Nervenkr 223: 15–33PubMedCrossRefGoogle Scholar
  6. Crook T, Bartus R, Ferris S, Gershon S (1986) Treatment development strategies for Alzheimer’s disease. Mark Powley, Connecticut, pp 385–450Google Scholar
  7. Gottfries CG (1983) Biochemical changes in blood and cerebrospinal fluid. In: Reisberg (ed) Alzheimer’s disease. The standard reference. The Free Press, Collier MacMillan, London, pp 122–130Google Scholar
  8. Gottfries CG, Karlsson I, Svennerholm L (1985) Senile dementia — a “white matter” disease? In: Gottfries CG (ed) Normal aging. Alzheimer’s disease and senile dementia. Aspects on etiology, pathogenesis, diagnosis and treatment. Proceedings of two symposia held at the C.I.N.P. Congress, June 22–23, 1984, Florence, Italy. L’Université de Bruxelles, Brussels, pp 11–118Google Scholar
  9. Gustafson L (1985) Differential diagnosis with special reference to treatable dementias and pseudodementia conditions. Dan Med Bull 32 [Suppl 1]: 55–60PubMedGoogle Scholar
  10. Gustafson L, Nilsson L (1982) Differential diagnosis of presenile dementia on clinical grounds. Acta Psychiatr Scand 65: 194–209PubMedCrossRefGoogle Scholar
  11. Gustafson L, Risberg J, Silverskiöld P (1981) Regional cerebral blood flow in organic dementia and affective disorders. In: Mendlewicz J, van Prag HM (eds) Advances in biological psychiatry, vol 6. Karger, Basel, pp 109–116Google Scholar
  12. Hachinski VC, Iliff LB, Phil M, Zilhka E, Du Boulai GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637PubMedCrossRefGoogle Scholar
  13. Heston LL, Mastri AR, Anderson E, White J (1981) Dementia of the Alzheimer type: clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 38: 1085–1090PubMedCrossRefGoogle Scholar
  14. Johanson AM, Gustafson L, Risberg J (1986) Behavioural observations during performance of the WAIS Block Design Test related to abnormalities of regional cerebral blood flow in organic dementia. J Clin Exp Neuropsychol 8: 201–209PubMedCrossRefGoogle Scholar
  15. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465–479PubMedCrossRefGoogle Scholar
  16. Katzman R (1976) The prevalence and malignancy of Alzheimer’s disease. Arch Neurol 33: 217–218PubMedCrossRefGoogle Scholar
  17. Kaye JA, May C, Daly E, Atack JR, Sweeney DJ, Luxenberg JS, Kay AD, Kaufman S, Milstien S, Friedland RP, Rapoport SI (1988) Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal feastures. Neurology 38: 554–557PubMedGoogle Scholar
  18. Kral VA (1962) Senescent forgetfulness: benign and malignant. J Can Med Assoc 86: 257–260Google Scholar
  19. Lauter H (1970) Über Spätformen der Alzheimerschen Krankheit and ihre Beziehung zur senilen Demenz. Psychiatr Clin 3: 169–189Google Scholar
  20. Loeb C, Gandolfo C (1983) Diagnostic evaluation of degenerative and vascular dementia. Stroke 14: 399–401PubMedCrossRefGoogle Scholar
  21. Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type. Evidence of subgroups. Neurology 35: 453–461PubMedGoogle Scholar
  22. Portera-Sanchez A, del Ser T, Bermejo (1982) Clinical diagnosis of senile dementia of Alzheimer type and vascular dementia. In: Perry RD, Bolis SL, Toffano F (eds) Neural aging and its implications in human neurological pathology. Raven Press, New York, pp 169–188 (Aging, vol 18 )Google Scholar
  23. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer’s disease. Br Med J 288: 961–964CrossRefGoogle Scholar
  24. Sjögren T, Sjögren H, Lindgren AGH (1952) Morbus Alzheimer and morbus Pick. A genetic, clinical and pathoanatomical study. Acta Psychiatr Neurol Scand [Suppl 82]Google Scholar
  25. Svennerholm L, Gottfries CG, Karlsson I (1988) Neurochemical changes in white matter of patients with Alzheimer’s disease. In: Serlupi Crescenzi G (ed) A multi-disciplinary approach to myelin disease. Plenum Publishing Corporation, pp 319–328Google Scholar
  26. Verma MP, Greiffenstein MF, Verma N, King SD, Caldwell DL (1987) Electrophysiologic validation of two categories of demential — cortical and subcortical. Clin Electroencephalogr 18: 26–33PubMedGoogle Scholar
  27. Wallin A, Blennow K, Uhleman C, Långström G, Gottfries CG (1989a) White matter low attenuation on computed tomography in Alzheimer’s disease and vascular dementia — diagnostic and pathogenetic aspects. Acta Neurol Scand 80: 518–523PubMedCrossRefGoogle Scholar
  28. Wallin A, Alafuzoff I, Carlsson A, Eckernäs SÅ, Gottfries CG, Karlsson I, Svennerholm L, Winblad B (1989b) Neurotransmitter deficits in a nonmulti-infarct category of vascular dementia. Acta Neurol Scand 79: 397–406PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1990

Authors and Affiliations

  • C. G. Gottfries
    • 1
  1. 1.Department of Psychiatry and NeurochemistryGothenburg UniversitySweden

Personalised recommendations